Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Ng Shield

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Not Yet Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06982495Not ApplicableNot Yet RecruitingPrimary

Comparing Two Methods to Measure Nasogastric Tube Length

NCT00781248Phase 2CompletedPrimary

Safety and Efficacy Study of the NG Shield, a Device Intended to Reduce Pain and Discomfort Level Related to Nasogasstric Tube Usage

Showing all 2 trials

Research Network

Common Treatments

  • Ng Shield1
  • Conventional Blind Insertion1
  • Nckung System1

Active Sponsors

  • National Cheng-Kung University Hospital1
  • Nanovibronix1

Top Investigators

Related Conditions

  • Intubation Depth1
  • Intubation Intraesophageal1
  • Intubation Times1
  • Intubation Complication1

Activity Timeline